BUSINESS DEVELOPMENT

Abdi İbrahim’s aim is to incorporate products that will consolidate its position in prominent treatment areas in order to further its efforts on improving human health.

The Business Development Unit has focused on developing and utilizing opportunities in In-Licensing, Co-Marketing and production services in order to develop the company’s product portfolio. At the same time, the Business Development Unit is also actively working on searching new areas of business, identifying new products for international markets, and assessing acquisition and partnership opportunities in line with Abdi İbrahim’s strategic vision for 2025.

• 

  Production capacity of
  630 million units

• 

  A GMP facility equipped with the latest, EU-certified technologies

• 

  Capable of producing biotechnological products as well as solid, powder inhaler, effervescent, liquid and semi-solid dosage forms.

• 

  Reliable business partnership in terms of information security and IP rights

• 

  A committed and experienced technical team

• 

  Single point of contact for Business Development

Having completed a variety of collaborations on international platforms, Abdi İbrahim is set to improve its existing production partnerships by increasing the business volumes of existing customers and adding new customers to its portfolio with its facilities in Kazakhstan, Algeria, and Istanbul. Contact us at info.licensing@abdiibrahim.com.tr for production service partnerships.